SmitW., SchoutenN., van den BergJ.W., LangedijkM.J., StruijkD.G., KredietR.T., for The Netherlands Ultrafiltration Failure Study Group. Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross-sectional study.Perit Dial Int2004; 24: 562–70.
2.
NakayamaM., KawaguchiY., for The Water and Electrolyte Balance (WEB) Study Group in CAPD. Multicenter survey on hydration status and control of blood pressure in Japanese CAPD patients.Perit Dial Int2002; 22: 411–14.
3.
WilkieM.E., PlantM.J., EdwardsL., BrownC.B.Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technical survival.Perit Dial Int1997; 17: 84–7.
4.
Pecoits-FilhoR., MujaisS., LindholmB.Future of icodextrin as an osmotic agent in peritoneal dialysis.Kidney Int Suppl2002; 81: S80–7.
5.
WolfsonM., PirainoB., HamburgerR.J., MortonA.R., for The Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.Am J Kidney Dis2002; 40: 1055–65.
6.
DaviesS.J., BrownE.A., FrandsenN.E., RodriguesA.S., Rodriguez-CarmonaA., VychytilA., on behalf of the EAPOS Group. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effect of glucose and icodextrin prescription.Kidney Int2005; 67: 1609–15.
7.
CookerL.A., HolmesC.J., HoffC.M.Biocompatibility of icodextrin.Kidney Int Suppl2002; 81: S34–45.
8.
DaviesS.J., PlumJ., WoodrowG., JohanssonA.C., WilliamsP., DonovanK.Increasing our understanding of the mechanism of action of icodextrin [Abstract].Perit Dial Int2004; 24(Suppl 2): S33.
9.
KoningsCJAM, KoomanJ.P., SchonckM., GladziwaU., WirtzJ., van den Wall BakeA.W.Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.Kidney Int2003; 63: 1556–63.